Heptameric Targeting Ligands against EGFR and HER2 with High Stability and Avidity

• Dongwook Kim,

  Affiliations Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Yitang Yan,

  Current address: Laboratory of Neurobiology, National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina, United States of America

  Affiliations Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• C. Alexander Valencia,

  Current address: Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America; Department of Pediatrics, University of Cincinnati Medical School, Cincinnati, Ohio, United States of America

  Affiliations Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Rihe Liu

  * E-mail: rliu@email.unc.edu

  Affiliations Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯